imiquimod has been researched along with Endothelioma, Lymphatic in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 4 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Can Kuru, B; Cinel, L; Ergun, T; Salman, A; Sarac, G; Yucelten, AD | 1 |
Figueroa, O; Monteagudo, B; Suárez-Amor, O; Varela-Veiga, A | 1 |
Millán-Cayetano, JF; Padilla-España, L; Repiso-Jiménez, JB | 1 |
Liu, LF; Mao, XH; Wang, JY | 1 |
Bikowski, JB; Dumont, AM | 1 |
Sun, ZJ; Zhang, WF; Zhao, YF | 1 |
6 other study(ies) available for imiquimod and Endothelioma, Lymphatic
Article | Year |
---|---|
Acquired progressive lymphangioma: Case report with partial response to imiquimod 5% cream.
Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Child, Preschool; Diagnosis, Differential; Female; Humans; Imiquimod; Lymphangioma; Sarcoma, Kaposi; Skin; Skin Neoplasms | 2017 |
Genital Warts, Lymphangioma, and Treatment with Imiquimod.
Topics: Aminoquinolines; Condylomata Acuminata; Female; Humans; Imiquimod; Lymphangioma; Vulva | 2018 |
Genital Warts, Lymphangioma, and Treatment with Imiquimod.
Topics: Adult; Antineoplastic Agents; Condylomata Acuminata; Diagnosis, Differential; Female; Humans; Imiquimod; Lymphangioma; Vulvar Neoplasms | 2018 |
Treatment of lymphangioma circumscriptum with topical imiquimod 5% cream.
Topics: Administration, Cutaneous; Adolescent; Aminoquinolines; Antineoplastic Agents; Female; Humans; Imiquimod; Lymphangioma; Male; Skin Neoplasms | 2012 |
Lymphangioma circumscriptum: treatment with hypertonic saline sclerotherapy.
Topics: Adjuvants, Immunologic; Adult; Aminoquinolines; Female; Humans; Imiquimod; Lymphangioma; Saline Solution, Hypertonic; Sclerosing Solutions; Sclerotherapy | 2005 |
Immune response: A possible role in the pathophysiology of hemangioma.
Topics: Aminoquinolines; Antineoplastic Agents; CD4-Positive T-Lymphocytes; Hemangioma; Humans; Imiquimod; Indoleamine-Pyrrole 2,3,-Dioxygenase; Lymphangioma | 2007 |